263 related articles for article (PubMed ID: 25020163)
1. Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin.
Kochiashvili D; Khuskivadze A; Kochiashvili G; Koberidze G; Kvakhajelidze V
Georgian Med News; 2014 Jun; (231):11-6. PubMed ID: 25020163
[TBL] [Abstract][Full Text] [Related]
2. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of recurrent urinary infections using Solco Urovac, a polymicrobial vaccine].
Prát V; Matousovic K; Horcicková M; Hatala M; Milotová Z
Cas Lek Cesk; 1989 Aug; 128(35):1106-9. PubMed ID: 2605612
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy with Solco Urovac vaccine in chronic genitourinary infection].
Donovski L
Khirurgiia (Sofiia); 1989; 42(4):28-30. PubMed ID: 2585977
[TBL] [Abstract][Full Text] [Related]
5. Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.
Flower A; Harman K; Lewith G; Moore M; Bishop FL; Stuart B; Lampert N
Trials; 2016 Jul; 17():358. PubMed ID: 27460108
[TBL] [Abstract][Full Text] [Related]
6. Characterization of host and escherichia coli strains causing recurrent urinary tract infections based on molecular typing.
Kao CY; Zhang YZ; Yang DC; Chen PK; Teng CH; Lin WH; Wang MC
BMC Microbiol; 2023 Mar; 23(1):90. PubMed ID: 36997841
[TBL] [Abstract][Full Text] [Related]
7. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for the prevention of recurrent urinary tract infections: a systematic review.
Aziminia N; Hadjipavlou M; Philippou Y; Pandian SS; Malde S; Hammadeh MY
BJU Int; 2019 May; 123(5):753-768. PubMed ID: 30378242
[TBL] [Abstract][Full Text] [Related]
9. The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children.
Nayir A; Emre S; Sirin A; Bulut A; Alpay H; Tanman F
Vaccine; 1995 Aug; 13(11):987-90. PubMed ID: 8525693
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of urinary tract infections with SolcoUrovac].
Litschgi M
Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):107-10. PubMed ID: 3106132
[TBL] [Abstract][Full Text] [Related]
11. Prevention of recurrent urinary tract infections.
Wagenlehner FM; Vahlensieck W; Bauer HW; Weidner W; Piechota HJ; Naber KG
Minerva Urol Nefrol; 2013 Mar; 65(1):9-20. PubMed ID: 23538307
[TBL] [Abstract][Full Text] [Related]
12. Role of Vaccines for Recurrent Urinary Tract Infections: A Systematic Review.
Prattley S; Geraghty R; Moore M; Somani BK
Eur Urol Focus; 2020 May; 6(3):593-604. PubMed ID: 31806578
[TBL] [Abstract][Full Text] [Related]
13. [Vaccinations in recurrent urinary tract infections--an observation study relating to health economy].
Lenk VS; Dorsch B
Aktuelle Urol; 2009 Nov; 40(6):360-5. PubMed ID: 19899016
[TBL] [Abstract][Full Text] [Related]
14. [Recurrent urinary tract infections].
Pigrau-Serrallach C
Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 4():28-39. PubMed ID: 16854356
[TBL] [Abstract][Full Text] [Related]
15. Clinical and microbiological characteristics of Klebsiella pneumoniae from community-acquired recurrent urinary tract infections.
Lin WH; Kao CY; Yang DC; Tseng CC; Wu AB; Teng CH; Wang MC; Wu JJ
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1533-9. PubMed ID: 24756209
[TBL] [Abstract][Full Text] [Related]
16. ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial.
Forbes R; Ali A; Abouhajar A; Brennand C; Brown H; Carnell S; Chadwick T; Eardley I; Lecouturier J; Mossop H; Pearce I; Pickard R; Thiruchelvam N; Walton K; Wilkinson J; Harding C
Trials; 2018 Nov; 19(1):616. PubMed ID: 30413181
[TBL] [Abstract][Full Text] [Related]
17. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.
Uehling DT; Hopkins WJ; Balish E; Xing Y; Heisey DM
J Urol; 1997 Jun; 157(6):2049-52. PubMed ID: 9146577
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for recurrent urinary tract infection in young women.
Scholes D; Hooton TM; Roberts PL; Stapleton AE; Gupta K; Stamm WE
J Infect Dis; 2000 Oct; 182(4):1177-82. PubMed ID: 10979915
[TBL] [Abstract][Full Text] [Related]
19. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials.
Beerepoot MA; Geerlings SE; van Haarst EP; van Charante NM; ter Riet G
J Urol; 2013 Dec; 190(6):1981-9. PubMed ID: 23867306
[TBL] [Abstract][Full Text] [Related]
20. Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age.
Ahmed AF; Solyman AA; Kamal SM
Int Urogynecol J; 2016 Aug; 27(8):1245-53. PubMed ID: 26872648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
